The XPO1 inhibitor selinexor ameliorates bleomycin-induced pulmonary fibrosis in mice via GBP5/NLRP3 inflammasome signaling

博莱霉素 肺纤维化 CTGF公司 支气管肺泡灌洗 医学 羟脯氨酸 癌症研究 药理学 纤维化 肌成纤维细胞 体内 细胞外基质 病理 化学 免疫学 生物 内科学 生物化学 化疗 受体 生物技术 生长因子
作者
Jia Zhang,Yihua Zhang,Qi Chen,Yong Qi,Xiaoju Zhang
出处
期刊:International Immunopharmacology [Elsevier BV]
卷期号:130: 111734-111734 被引量:1
标识
DOI:10.1016/j.intimp.2024.111734
摘要

Pulmonary fibrosis is an irreversible and progressive lung disease with limited treatments available. Selinexor (Sel), an orally available, small-molecule, selective inhibitor of XPO1, exhibits notable antitumor, anti-inflammatory and antiviral activities. However, its potential role in treating pulmonary fibrosis is unknown. C57BL/6J mice were used to establish a pulmonary fibrosis model by intratracheal administration of bleomycin (BLM). Subsequently, Sel was administered intraperitoneally. Our data demonstrated that Sel administration ameliorated BLM-induced pulmonary fibrosis by increasing mouse body weights; reducing H&E staining, Masson staining scores, and shadows in mouse lung computed tomography (CT) images, decreasing the total cell and neutrophil counts in the lung and bronchoalveolar lavage fluid (BALF); and decreasing the levels of TGF-β1. We next confirmed that Sel reduced the deposition of extracellular matrix (ECM) components in the lungs of BLM-induced pulmonary fibrosis mice. We showed that collagen I, alpha-smooth muscle actin (α-SMA), and hydroxyproline levels and the mRNA levels of Col1a1, Eln, Fn1, Ctgf, and Fgf2 were reduced. Mechanistically, tandem mass tags (TMT)- based quantitative proteomics analysis revealed a significant increase in GBP5 in the lungs of BLM mice but a decrease in that of BLM + Sel mice; this phenomenon was confirmed by western blotting and RT-qPCR. NLRP3 inflammasome signaling was significantly enriched in both the BLM group and BLM + Sel group based on GO and KEGG analyses of differentially expressed proteins between the groups. Furthermore, Sel reduced the expression of NLRP3, cleaved caspase 1, and ASC in vivo and in vitro, and decreased the levels of IL-1β, IL-18, and IFN-r in lung tissue and BALF. SiRNA-GBP5 inhibited NLRP3 signaling in vitro, and overexpression of GBP5 inhibited the protective effect of Sel against BLM-induced cellular injury. Taken together, our findings indicate that Sel ameliorates BLM-induced pulmonary fibrosis by targeting GBP5 via NLRP3 inflammasome signaling. Thus, the XPO1 inhibitor - Sel might be a potential therapeutic agent for pulmonary fibrosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雪花发布了新的文献求助10
2秒前
周全完成签到 ,获得积分10
6秒前
water应助科研通管家采纳,获得10
7秒前
Owen应助科研通管家采纳,获得10
7秒前
内向忆南完成签到,获得积分10
10秒前
翱翔者完成签到 ,获得积分10
13秒前
kryptonite完成签到 ,获得积分10
13秒前
月军完成签到,获得积分10
14秒前
欢呼寻冬完成签到 ,获得积分10
15秒前
西安浴日光能赵炜完成签到,获得积分10
16秒前
Joy完成签到 ,获得积分10
17秒前
Olsters完成签到 ,获得积分10
20秒前
老程完成签到,获得积分10
21秒前
zyb完成签到 ,获得积分10
24秒前
laber完成签到,获得积分0
24秒前
yue完成签到,获得积分10
24秒前
与共完成签到 ,获得积分10
27秒前
量子星尘发布了新的文献求助10
28秒前
gzf完成签到 ,获得积分10
29秒前
29秒前
D调的华丽完成签到,获得积分10
33秒前
xingxinghan完成签到 ,获得积分10
33秒前
ColinWine完成签到 ,获得积分10
36秒前
mix完成签到,获得积分10
36秒前
动听的谷秋完成签到 ,获得积分10
37秒前
刻苦努力的火龙果完成签到,获得积分10
38秒前
lling完成签到 ,获得积分10
41秒前
听寒完成签到,获得积分10
43秒前
珍珠火龙果完成签到 ,获得积分10
46秒前
似水流年完成签到 ,获得积分10
47秒前
sysi完成签到 ,获得积分10
1分钟前
绿波电龙完成签到,获得积分10
1分钟前
1分钟前
ZZzz完成签到 ,获得积分10
1分钟前
wujiwuhui发布了新的文献求助10
1分钟前
1分钟前
梦梦的小可爱完成签到 ,获得积分10
1分钟前
xinjie发布了新的文献求助10
1分钟前
1分钟前
蛋花肉圆汤完成签到,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022